Improving vaccine effectiveness by targeting immune cells in the skin
Combinatorial control of TLR signaling using self-assembly of immune signals on microneedle arrays to access the skin niche
This study is exploring a new way to make vaccines work better by using tiny microneedles to deliver special signals directly to immune cells in your skin, which could help your body fight off diseases more effectively.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-11003283 on NIH RePORTER |
What this research studies
This research focuses on enhancing vaccine responses by utilizing microneedle arrays to deliver immune signals directly to specialized immune cells in the skin. By combining antigens and toll-like receptor agonists, the study aims to activate these immune cells, which play a crucial role in initiating strong immune responses. The approach involves self-assembly of these signals on microneedles, allowing for precise targeting and potentially improved vaccine efficacy against various pathogens. Patients may benefit from more effective vaccines that provide better protection against diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are seeking vaccination or are at risk of infectious diseases that could be targeted by improved vaccines.
Not a fit: Patients who are not seeking vaccination or have contraindications to vaccination may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that enhance immune responses and provide better protection against infectious diseases.
How similar studies have performed: Previous research has shown that targeting immune cells with specific signals can enhance vaccine responses, indicating potential success for this novel approach.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Edwards, Camilla Marie — Univ of Maryland, College Park
- Study coordinator: Edwards, Camilla Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.